ER | Jotup

Cyient Recognized in Leadership Positions across Eight Verticals in Zinnov Zones

Retrieved on:

Tuesday, February 13, 2024

Cyient was recognized for its innovation and solution development in a range of industries, spanning Aerospace, Automotive, Semiconductor, and Telehealth, among others.

Key Points:

Cyient was recognized for its innovation and solution development in a range of industries, spanning Aerospace, Automotive, Semiconductor, and Telehealth, among others.
Cyient's recognition in the Zinnov Zones 2023 assessment is a testament to the company's exceptional capabilities, industry expertise, and innovative approach to solving complex engineering challenges.
Marking a groundbreaking milestone, Cyient debuted in Data Analytics and AI with a leadership ranking, outpacing competitors in Generative AI.
The Zinnov Zones 2023 report provides a comprehensive analysis of service providers in the engineering ecosystem.

Fierce Healthcare Names Oshi Health a "Fierce 15" Company of 2024

Retrieved on:

Monday, February 12, 2024

NEW YORK, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Oshi Health today announced that it has been named a "Fierce 15" company for 2024 by Fierce Healthcare. Oshi was recognized as one of the most innovative private healthcare companies looking to change the face of the industry by delivering effective, proven digestive care in a way that benefits patients, providers, health plans, and employers.

Key Points:

Annual special report recognizes virtual specialty care innovator for transforming equity and access to care, achieving value-based health insurance contracts, and improving patient and provider experiences in digestive healthcare
NEW YORK, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Oshi Health today announced that it has been named a "Fierce 15" company for 2024 by Fierce Healthcare.
"We are honored to be named a 'Fierce 15' innovator," said Sam Holliday, Oshi Health CEO.
Oshi was deemed a "Fierce" company for 2024 based on achievements in three core areas below, all core to Oshi's mission and values.
Read the 2024 Fierce 15 report: https://www.fiercehealthcare.com/special-reports/healthcare-conferences-...
Earlier this month, Oshi Health was also named to the 2024 New York Digital Health 100 (DH100) for the third year, recognition by Digital Health New York (DHNY) that highlights the most exciting and innovative digital health startups in New York.

Mile Bluff Medical Center Now Live with MEDITECH Expanse Search and Summarization, Powered by Google Health

Retrieved on:

Thursday, February 8, 2024

Mile Bluff Medical Center (Mauston, WI) just took a significant step forward in reducing clinician burdens by going live with MEDITECH’s new AI-powered Expanse search and summarization capabilities powered by Google Health.

Key Points:

Mile Bluff Medical Center (Mauston, WI) just took a significant step forward in reducing clinician burdens by going live with MEDITECH’s new AI-powered Expanse search and summarization capabilities powered by Google Health.
Mile Bluff’s Expanse EHR uses Google Health’s advanced summarization capabilities to synthesize and organize this data, giving clinicians timely and intuitive access to a more holistic view of patients and their conditions.
“Our providers saw an immediate impact upon going live with the search and summarization functionality,” explains Randy Brandt, PA-C, a primary care physician assistant and team lead for the project.
“They appreciated how they can launch the functionality directly from their Expanse Chart Viewer to get a complete longitudinal view of their patients.

Red Door Interactive Wins Gold in "Best Crisis Communications" at 2023 US Agency Awards

Retrieved on:

Wednesday, February 7, 2024

Partnership, SAN, Parent, Patient satisfaction, Hospital, Fever, Patient, Marketing, CHOC, Health

SAN DIEGO, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Today, Red Door Interactive, a fiercely independent, nationally renowned marketing agency, announced it won US Agency Awards' "Best Crisis Communications" category for its Fever Campaign, in partnership with Children's Hospital of Orange County (CHOC). The agency strategically partnered with CHOC amid the winter season rise of pediatric viral outbreaks, leading to overcrowded emergency rooms and increased strain on CHOC's emergency department. Red Door Interactive's Fever Campaign addressed one of CHOC's most acute challenges: supporting parents with proper fever protocol for their children.

Key Points:

SAN DIEGO, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Today, Red Door Interactive , a fiercely independent, nationally renowned marketing agency, announced it won US Agency Awards ' "Best Crisis Communications" category for its Fever Campaign, in partnership with Children's Hospital of Orange County (CHOC).
Red Door Interactive's Fever Campaign addressed one of CHOC's most acute challenges: supporting parents with proper fever protocol for their children.
"This campaign aims to equip parents with the necessary information to make informed decisions about their child's care," said Hannah Toy, business manager at at Red Door Interactive.
With its potential for scalability, Red Door Interactive's Fever Campaign offers a blueprint for effective marketing and crisis response in pediatric and adult healthcare.

Legal-Bay Launches New Site to Cater to Maritime Lawsuit Plaintiffs and Victims with Jones Act Claims

Retrieved on:

Monday, February 5, 2024

Admiralty law, Gulf of Mexico, Hospital, Pacific Ocean, Injury, Accident, Lawsuit, Rehabilitation, Insurance

MIAMI, Feb. 5, 2024 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Pre-Settlement Funding Company, announced today that they have launched a new website page dedicated solely to Maritime employees and Jones Act plaintiffs who need funding for their Maritime case or Jones Act lawsuit.

Key Points:

MIAMI, Feb. 5, 2024 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Pre-Settlement Funding Company, announced today that they have launched a new website page dedicated solely to Maritime employees and Jones Act plaintiffs who need funding for their Maritime case or Jones Act lawsuit.
Under Maritime laws, seamen and maritime employees have rights and are protected by law if or when they become injured at work or at sea.
Offshore oil rig employees may also be covered and approved for maritime or Jones Act lawsuit loan funding.
To apply right now for the quick approval process on your Maritime lawsuit loan, Jones Act lawsuit settlement loan, maritime pre-settlement funding request, Jones Act pre-settlement funding, maritime settlement advance, loan on maritime settlement, fast loan on maritime pending lawsuit, Jones Act settlement loan, or any other type of maritime case or Jones Act case pending settlement funding request, please call Legal-Bay's 24-hour hotline at 877.571.0405 or visit: https://lawsuitssettlementfunding.com/maritime-jones-act.php
Legal-Bay is an industry leader in lawsuit cash advance funding, known as "the best lawsuit loan company out there" or "one of the best lawsuit loan companies around."

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203

Retrieved on:

Thursday, January 25, 2024

Patient, GUD, Standard of care, TSX, Stomach, Absorption, Trial of the century, CNS, Pharmaceutical industry

MONTREAL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal"), granting Knight the exclusive rights to seek regulatory approval and commercialize IPX203 in Canada and Latin America.

Key Points:

MONTREAL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal"), granting Knight the exclusive rights to seek regulatory approval and commercialize IPX203 in Canada and Latin America.
IPX203 is a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules designed for the treatment of Parkinson’s disease.
“This transaction builds on our strategy of expanding our CNS portfolio,” said Samira Sakhia, President and CEO of Knight.
“We see IPX203 as a critical innovation that can meaningfully advance the standard of care for Parkinson’s patients.”

Mindray Showcased Latest Innovations in Smart Hospital Solutions at Arab Health 2024

Retrieved on:

Monday, January 29, 2024

Medical imaging, Orthopedic surgery, ICU, Hospital, Minimally invasive procedure, Workflow, Medicine, TV80, Transport, ERAS, Medical device

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- Mindray ("the company"), a leading global provider of medical devices and solutions, is attending one of the largest exhibitions in the medical field, the Arab Health 2024 from Jan. 29 to Feb. 1.

Key Points:

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- Mindray ("the company"), a leading global provider of medical devices and solutions, is attending one of the largest exhibitions in the medical field, the Arab Health 2024 from Jan. 29 to Feb. 1.
This year, under the theme of "Exploring the Future of Smart Healthcare", Mindray showcased its latest innovations in Smart Hospital Solutions at its booth.
Expo visitors can witness Mindray's comprehensive product portfolio from ER, OR, ICU, ERAS, and Medical Imaging solutions to Orthopedics solutions at booth S1.
Following Arab Health 2024, Mindray will also participate at Medlab Middle East on Feb. 5-8, where it will be presenting its advanced total solutions in In-Vitro Diagnostics.

Elanco Launches Multi-Year Mission to Save 1 Million Puppies from Canine Parvovirus

Retrieved on:

Wednesday, January 17, 2024

Mortality, Parvoviridae, Veterinarian, Standard of care, Dog, USDA, Disease, ELAN, Education, Vaccine

GREENFIELD, Ind., Jan. 17, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today launched the first-of-its-kind, multi-year campaign to save 1 million puppies from unnecessary death from the highly contagious canine parvovirus (parvo). The Defend Puppies. Defeat Parvo. mission seeks to conquer a virus that, without timely and aggressive care, has a mortality rate as high as 91%1. An estimated 900 dogs are diagnosed with parvo daily2 in the U.S. – mostly unvaccinated puppies. Yet Elanco research revealed only 44% of dog owners know what parvo is, with 20% having no knowledge of the disease.3 With dog owners being the first line of defense in protecting their puppies, there is need for more wide-spread education.

Key Points:

Pledge Today to Save Puppies from Deadly Canine Parvovirus
GREENFIELD, Ind., Jan. 17, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today launched the first-of-its-kind, multi-year campaign to save 1 million puppies from unnecessary death from the highly contagious canine parvovirus (parvo).
mission strengthens Elanco's ability to reach more puppies, more quickly and includes the following:
Newly established Elanco's Defenders Fund offers up to $1 million in rebate incentives from Elanco to veterinarians who purchase the Canine Parvovirus Monoclonal Antibody.
In clinical efficacy studies, zero dogs treated with Elanco's Canine Parvovirus Monoclonal Antibody died, and the Canine Parvovirus Monoclonal Antibody treatment helped shorten the course of parvo, helping these puppies feel better, faster.
I pledge, because I know together, we can save 1 million puppies from parvo by 2030.

Orlando Middle School Students Scrubbed In As Vets for a Day at the World's Largest, Most Comprehensive Veterinary Conference

Retrieved on:

Tuesday, January 16, 2024

Latinx, Student, Hill, Veterinary medicine, VMX, VCA, CPR, Boehringer Ingelheim, Parent, Education, Veterinarian

ORLANDO, Jan. 16, 2024 /PRNewswire/ -- On the heels of Martin Luther King Jr. Day, the North American Veterinary Community (NAVC) and nationally-recognized veterinary certification program blendVET hosted some 80 middle school students from underserved communities in central Florida for a full day of hands-on learning at the 41st Veterinary Meeting and Expo, VMX 2024. The students enjoyed a day full of immersive activities alongside veterinarians and veterinary nurses/technicians.

Key Points:

The students enjoyed a day full of immersive activities alongside veterinarians and veterinary nurses/technicians.
Our blend pathway program has opened new doors for underserved youth to pursue veterinary careers in the years to come.
Veterinary medicine is one of the least diverse fields in America.
The blendVET faculty shared personal stories of resilience and success in veterinary medicine with the support of their families.

HARMAN Named a “Leader” in 2023 Zinnov Zones Ratings of Global ER&D Service Providers

Retrieved on:

Tuesday, January 16, 2024

This is the eighth consecutive year that HARMAN has been recognized in the Zinnov Zones for Digital Engineering and ER&D services 2023 ratings .

Key Points:

This is the eighth consecutive year that HARMAN has been recognized in the Zinnov Zones for Digital Engineering and ER&D services 2023 ratings .
This combination has helped HARMAN anchor its leadership position in the Zinnov Zones 2023 Ratings for Digital Engineering and ER&D services ."
The Zinnov Zones ratings have become the industry standard for benchmarking service providers across capabilities such as ER&D Services, Digital Services, IoT Services and Media and Technology.
Zinnov’s annual ratings of Global ER&D Service Providers for 2023 evaluated ~60 Global ER&D Services players and rated HARMAN as a leader in 15 ER&D categories and two mentions as notable player in Digital Engineering Services, and Industrial.